Articles tagged with Oncology
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A new study suggests that monitoring patients' activity levels prior to chemoradiation therapy for lung cancer can predict treatment outcomes. Inactive patients are more likely to experience hospitalization, treatment delays, and disease recurrence, while active patients have better survival rates.
A three-year longitudinal study found that having a hematologist mentor during medical education is associated with an increased likelihood of fellows specializing in hematology. Fellows who co-authored papers or engaged in research activities with mentors in hematology were more likely to pursue careers in the field.
Professor Fatima Cardoso will receive the award for her foresight in understanding advanced breast cancer and launching the ABC Global Alliance. The alliance, now an independent organization, aims to improve lives of patients worldwide through awareness and advocacy.
The CheckMate-227 trial found that the combination of nivolumab and low-dose ipilimumab improves overall survival in patients with advanced non-small cell lung cancer compared to chemotherapy. The treatment was well-tolerated, with a low rate of discontinuation and treatment-related toxicities.
Researchers from University of Colorado Cancer Center Department of Radiation Oncology won the IAEA safety competition by recognizing the importance of a positive attitude towards radiation safety and developing department-wide processes for communicating safety standards. The team used Safety Month as an opportunity to broadcast and t...
A 16-year study of 452,000 Europeans found a positive association between artificially sweetened and sugar-sweetened soft drinks and an increased risk of death from circulatory and digestive diseases. The findings support public health campaigns aimed at limiting soft drink consumption.
A survey of early career oncologists found that women are less likely to attend scientific meetings due to family obligations. Onsite childcare is essential to promote work-life integration and increase female participation.
A new diagnostic test has the potential to determine if breast cancer patients require chemotherapy, giving them control over their treatment. The test uses gene profiling to identify low-risk patients who may not benefit from chemotherapy.
Susan Band Horwitz, an NFCR fellow, has been named a Giant of Cancer Care for her pioneering work on Taxol and its role in stabilizing microtubules to prevent cancer cell growth. Her research enabled the development of life-saving medications for ovarian, breast, and lung cancers.
Christine Menias, MD, is recognized for her dedication to radiology education, with a notable track record of instructional courses and awards. She has been named the 2019 ARRS Distinguished Educator for her inspirational teaching and commitment to improving competence and patient outcomes.
The global HER2 testing survey reveals major access and affordability issues in low and middle income countries, with some upper middle income countries also affected. The study suggests that governments need better information to set planning priorities for investing in infrastructure, testing, and treatment.
A recent study published in JAMA found that magic mouthwash significantly reduced pain from oral mucositis, a common side effect of radiation therapy for head and neck cancers. The treatment, which contains diphenhydramine, lidocaine, and antacids, was well-tolerated by patients and outperformed placebo.
Consuming garlic and onions has been shown to lower the risk of colorectal cancer in a Chinese study involving 833 patients. Adults who ate high amounts of allium vegetables had an 79% lower chance of developing the disease compared to those who consumed low amounts.
A large European study found that small lung spots in rhabdomyosarcoma patients do not affect survival prospects or require aggressive treatment, unlike larger metastases.
The MYSTIC trial found that first line immunotherapy combination with durvalumab and tremelimumab does not improve overall survival in unselected patients with lung cancer. However, a subgroup of patients with high tumour mutational burden showed improved overall survival with the combination treatment.
The NRG Oncology clinical trial BR001 found that SBRT is safe for patients with 2 metastases or 3-4 metastases in specific locations, including peripheral lung and abdomen/pelvic. The study showed zero protocol-defined dose-limiting toxicities across evaluable anatomic locations.
Oncologists require more education on the use of biosimilars, which could increase patient access to innovative therapies due to economic constraints. ESMO supports their use as cheaper alternatives to reference biologics, promoting sustainable and widely accessible cancer care.
Researchers found a link between higher levels of interleukin-10 (IL-10) and lower disease-free survival rates after radiotherapy. Elevated CRP levels, a marker of inflammation, were not associated with DFS.
A study found huge variations in time between European countries to reach health technology assessment decisions on new cancer drugs, with some taking over a year. The average decision time was longer than one year in England and Scotland compared to Germany and France.
Researchers examined federal payment databases to determine payments made to oncologists who authored studies in high-impact journals. The study found that a substantial proportion of payments were not disclosed, which could lead to bias and influence clinical trial results.
Investigative report finds 40 physician advisors took over $10,000 from drug makers after reviewing drugs, while 26 received more than $100,000 in post-hoc earnings. The FDA's honor system for disclosing financial interests may be ineffective in detecting conflicts of interest.
Fabrice Barresi has been awarded the Heine H. Hansen Award by European Society for Medical Oncology (ESMO) and International Association for the Study of Lung Cancer (IASLC). This award is presented annually at the European Lung Cancer Congress to a lung cancer investigator who has made a special contribution to this field.
Dr. Jerry A. Shields, a pioneering ophthalmologist, received the inaugural Brady-Shields Endowed Chair in Ocular Oncology at Wills Eye Hospital. The chair honors Dr. Luther W. Brady Jr., Dr. Carol L. Shields, and their contributions to ocular oncology research.
A group of authors from IQWiG has contradicted the American Society of Clinical Oncology's conclusion that MammaPrint can identify patients who do not require chemotherapy. The IQWiG analysis found a statistically significant disadvantage of the test for disease-free survival in certain patient groups.
The combination of chemotherapy and immunotherapy significantly improves progression-free survival in patients with advanced non-squamous NSCLC. The study showed that the addition of atezolizumab to bevacizumab and chemotherapy leads to a median PFS of 8.3 months, compared to 6.8 months with bevacizumab and chemotherapy alone.
A modified XELIRI regimen with reduced doses of irinotecan and capecitabine has been shown to be non-inferior to FOLFIRI in terms of overall survival. The treatment, combined with bevacizumab, demonstrated favourable tolerability and efficacy comparable to XELOX plus bevacizumab.
A new study estimates that there were 854,000 new cases of liver cancer and 810,000 deaths worldwide in 2015. The majority of these cases were attributed to hepatitis B virus and alcohol consumption, highlighting the need for prevention and treatment strategies.
A survey of breast cancer clinic patients found that short- and long-term side effects were often better than anticipated, with 83% and 84% of respondents reporting similar expectations. Women reported lower fears and more positive experiences after treatment, highlighting the need to address misconceptions about radiation therapy.
At ESMO 2017, researchers presented 55 late-breaking abstracts and 1,736 selected abstracts, featuring breakthrough treatments for various cancers. The Congress emphasized the importance of preventing cancer through lifestyle changes and explored sustainable treatment options.
The MONARCH 3 trial showed that adding abemaciclib to endocrine therapy improved progression-free survival compared to endocrine therapy alone. Around one-third of women may not need a CDK 4/6 inhibitor as initial treatment.
Advance Care Planning (ACP) is a process where patients discuss their goals and preferences with relatives and health-care providers. The study recommends adapting ACP to the individual's readiness, updating conversations and documents regularly.
The ESMO-MCBS version 1.1 is the first major revision, introducing a new scale for single-arm studies in orphan diseases and for diseases with high unmet need. This updated tool will enable users to evaluate single-arm studies, previously only applicable to comparative studies.
ASTRO has recognized 43 researchers and clinical teams for their top-rated research abstracts, showcasing innovative science in radiation oncology. The Resident Clinical/Basic Science Research Abstract Award and Annual Meeting Travel Award also support early-career scientists, with a total of $45,000 in honorariums awarded.
Annals of Oncology has achieved an impressive Impact Factor score of 11.855, ranking it among the top 5% of oncology titles globally. The journal is recognized for its rapid and efficient peer-review publications on cutting-edge cancer research.
The IASLC published a comprehensive summary of the year's key developments in thoracic oncology, covering prevention, early detection, pathology, staging, surgery, adjuvant therapy, radiotherapy, and immunotherapy. The publication highlights significant progress in small cell lung cancer and malignant mesothelioma.
A phase III CONVERT trial study presented at ELCC 2017 shows that white blood cell boosting drugs are safe during concurrent chemo-radiotherapy of small cell lung cancer. The use of G-CSF had no significant negative impact on patient outcomes, supporting its use to mitigate neutropenia and increase chemotherapy delivery.
Rafal Dziadziuszko, a global leader in clinical thoracic oncology, has been awarded the Heine H. Hansen (HHH) Award by ESMO and IASLC for his lifetime contributions to lung cancer research and education globally.
A new study published in JAMA Oncology found that female adolescent and young adult cancer survivors have a higher risk of adverse birth outcomes, including preterm birth and low-birth weight. The study also suggests an increased likelihood of cesarean births among this population.
Researchers developed patient-size based diagnostic reference levels and achievable doses for 10 common CT head, neck and body examinations. The study found that using national benchmarks can reduce overall radiation dose and encourage facilities to optimize protocols.
A new study reveals that US men aged 18-59 have a high prevalence of genital HPV infection, with 45.2% of the population affected. The HPV vaccination coverage among eligible men is also low, at 10.7%, with age groups 23-27 and older showing higher rates.
Researchers found that a prostate-specific antigen (PSA) nadir greater than 0.5 ng/mL following radiation and androgen deprivation therapy identifies men prior to PSA failure who are at high risk for dying early. This marker can help identify men in need of more aggressive treatment, potentially making it curable.
A new study found a significant association between asbestos exposure and malignant mesothelioma in Eastern China. The research also highlights a notable difference in the male-to-female ratio of patients with mesothelioma, with more females affected than males.
A new analysis of 1981 patients with lower gastrointestinal symptoms found that the new criteria would miss nearly 20% of colorectal cancers. The study suggests that alarm features indicative of colorectal cancer are common among the general population, limiting their accuracy in predicting a diagnosis.
A special issue of Future Oncology examines the latest breakthroughs in prostate cancer imaging, including multiparametric MRI and PET imaging. The issue aims to provide a comprehensive overview of the field's current state and future directions.
A Phase III trial found ribociclib improved PFS of post-menopausal women with hormone receptor-positive metastatic breast cancer by 44 percent compared to hormone therapy alone. The study also showed a higher ORR in patients receiving ribociclib, with serious adverse events occurring less than five percent overall.
The phase III KEYNOTE-024 trial found pembrolizumab significantly improved progression-free survival by approximately four months compared to chemotherapy, with 80% of patients alive at six months on pembrolizumab. The treatment was also associated with a higher overall response rate and lower adverse events.
Sumitra Thongprasert has been awarded the second ESMO Women for Oncology award for her role as a role model for women in oncology. The award acknowledges her advocacy across Asia for female participation in the oncology workforce and promotion of women in leadership positions.
A new study published in JAMA Oncology found that 86% of National Comprehensive Cancer Network (NCCN) guideline authors had at least one reported financial conflict of interest. The study revealed significant payments to guideline authors, with an average of $10,011 for general payments and $236,066 for industry research payments.
Rates of early prostate cancer have continued to drop since the USPSTF recommendation, with localized/regional-stage incidence rates declining by 6-19% from 2011 to 2013. The decrease is attributed to changes in PSA testing rates and potentially unknown risk factors.
The first study assessing the clinical impact of ESMO-MCBS in a real-life context shows that the scale works reliably and reproducibly in advanced or metastatic disease. The study encourages its use in daily routine for novel treatments like immunotherapy.
The ESMO consensus guidelines reflect a personalized treatment approach to managing metastatic colorectal cancer, incorporating molecular markers and patient selection. The guidelines aim to improve outcomes by providing evidence-based recommendations for treatment options.
A large proportion of US cancer deaths might be prevented through adopting healthy lifestyles, including quitting smoking and exercising regularly. The study found that individuals who met specific criteria for a healthy lifestyle pattern had a significantly lower risk of developing cancer.
Suresh Senan, a renowned expert in radiation oncology, has been awarded the Heine H. Hansen Award for his pioneering work in lung cancer therapy and research. The award recognizes his significant contributions to the field of lung cancer on an international basis.
A multicenter study found that the HOSPITAL score accurately predicted patients at high risk of a 30-day potentially avoidable readmission. Patients identified as high risk were four times more likely to be readmitted within 30 days, and the score showed an excellent ability to identify these patients.
The Association for Molecular Pathology (AMP) has updated its pathology residency curriculum recommendations, focusing on 10 major molecular pathology topics. The new report aims to equip pathologists with the latest scientific breakthroughs and technological innovations in molecular pathology.
A study published in the American Journal of Clinical Oncology challenges the widely-held belief that low-dose radiation from medical imaging procedures can cause cancer. The authors argue that the linear no-threshold model, used to estimate cancer risks, has never been conclusively demonstrated by empirical evidence.
Dr. Norman Wolmark will present the William L. McGuire Memorial Lecture on the NSABP Clinical Trials' impact on early breast cancer management. Established in 1992, the McGuire Lectureship commemorates Dr. William McGuire's contributions to oncology.
The International Association for the Study of Lung Cancer (IASLC) has appointed Elsevier as the new publisher of its official journal, Journal of Thoracic Oncology. This partnership aims to enhance the journal's reputation and influence while expanding its global communities of contributors and readers.
The ESMO Women for Oncology Task Force aims to address inequalities among women oncologists, and the new award will be presented to Enriqueta Felip, who kick-started awareness of the lack of women oncologists in leadership roles. The award recognizes contributors who support the development of women in oncology.
BMJ has partnered with the European Society for Medical Oncology (ESMO) to publish a new open access cancer journal called ESMO Open. The journal will cover various aspects of cancer treatment and include study protocols and phase I clinical trials. It aims to provide rapid access to high-quality research on cancer care worldwide.